Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial

[1]  I. Almeida,et al.  Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. , 2018, The Lancet. Infectious diseases.

[2]  M. Olivera,et al.  Therapeutic drug monitoring of benznidazole and nifurtimox: a systematic review and quality assessment of published clinical practice guidelines. , 2017, Revista da Sociedade Brasileira de Medicina Tropical.

[3]  H. Garelick,et al.  Evolution of Chagas’ disease in Brazil. Epidemiological perspective and challenges for the future: a critical review , 2017, Perspectives in public health.

[4]  S. Yusuf,et al.  Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. , 2017, Journal of the American College of Cardiology.

[5]  J. Ramírez,et al.  New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients , 2015, Antimicrobial Agents and Chemotherapy.

[6]  S. Yusuf,et al.  Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. , 2015, The New England journal of medicine.

[7]  C. Padilla,et al.  Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients. , 2015, The Journal of molecular diagnostics : JMD.

[8]  Z. Cucunubá,et al.  Follow-up of an Asymptomatic Chagas Disease Population of Children after Treatment with Nifurtimox (Lampit) in a Sylvatic Endemic Transmission Area of Colombia , 2015, PLoS neglected tropical diseases.

[9]  G. Guyatt,et al.  Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. , 2014, The Cochrane database of systematic reviews.

[10]  Fernando Salvador,et al.  Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. , 2014, The New England journal of medicine.

[11]  G. Koren,et al.  Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults , 2014, PLoS neglected tropical diseases.

[12]  J. Gascón,et al.  Benznidazole-Related Adverse Drug Reactions and Their Relationship to Serum Drug Concentrations in Patients with Chronic Chagas Disease , 2012, Antimicrobial Agents and Chemotherapy.

[13]  J. Coura,et al.  Chronic phase of Chagas disease: why should it be treated? A comprehensive review. , 2011, Memorias do Instituto Oswaldo Cruz.

[14]  A. Assal,et al.  International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients , 2011, PLoS neglected tropical diseases.

[15]  O. Yun,et al.  Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières , 2009, PLoS neglected tropical diseases.

[16]  P. Hotez,et al.  Neglected tropical diseases , 2007, BMJ : British Medical Journal.

[17]  J. R. Cançado.  Long term evaluation of etiological treatment of chagas disease with benznidazole. , 2002, Revista do Instituto de Medicina Tropical de Sao Paulo.

[18]  J. Villar.  Commentary: Control of Chagas' disease: let's put people before vectors. , 2001, International journal of epidemiology.

[19]  E. Segura,et al.  Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. , 1998, The American journal of tropical medicine and hygiene.

[20]  J. Coura,et al.  [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]. , 1997, Revista da Sociedade Brasileira de Medicina Tropical.

[21]  Simonne Almeida e Silva,et al.  Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection , 1996, The Lancet.